IRIS
BERGAMINI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.898
AS - Asia 1.996
NA - Nord America 1.599
SA - Sud America 448
AF - Africa 31
OC - Oceania 12
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.986
Salva come PNG Salva come JPEG
Nazione #
RO - Romania 1.749
US - Stati Uniti d'America 1.528
SG - Singapore 830
CN - Cina 619
BR - Brasile 381
IT - Italia 365
SE - Svezia 231
HK - Hong Kong 220
RU - Federazione Russa 135
VN - Vietnam 125
DE - Germania 106
GB - Regno Unito 63
FI - Finlandia 49
IN - India 47
NL - Olanda 44
MX - Messico 34
AR - Argentina 32
CA - Canada 32
ES - Italia 31
FR - Francia 31
JP - Giappone 30
PL - Polonia 30
ID - Indonesia 23
TR - Turchia 21
AT - Austria 19
ZA - Sudafrica 19
IE - Irlanda 16
EC - Ecuador 10
BD - Bangladesh 9
PK - Pakistan 9
IQ - Iraq 8
LT - Lituania 8
CO - Colombia 7
AU - Australia 6
BE - Belgio 6
QA - Qatar 6
SA - Arabia Saudita 6
IL - Israele 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
NZ - Nuova Zelanda 4
UA - Ucraina 4
UY - Uruguay 4
UZ - Uzbekistan 4
CL - Cile 3
IR - Iran 3
KZ - Kazakistan 3
MY - Malesia 3
PY - Paraguay 3
VE - Venezuela 3
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
NG - Nigeria 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
TJ - Tagikistan 1
TN - Tunisia 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.986
Salva come PNG Salva come JPEG
Città #
Dallas 411
Singapore 398
Hong Kong 220
Ashburn 193
Beijing 135
Shanghai 135
Milan 119
New York 110
Hefei 94
Los Angeles 60
Ho Chi Minh City 46
Lawrence 46
Munich 46
Princeton 46
Boardman 41
São Paulo 41
Moscow 38
Hanoi 27
Warsaw 27
Turku 26
Vaprio d'Adda 25
Bergamo 24
Tokyo 24
Nuremberg 22
Denver 21
The Dalles 19
Boston 18
Helsinki 17
Brescia 16
Brooklyn 16
Dublin 16
London 16
Seattle 16
Chennai 15
Columbus 15
Johannesburg 15
Montreal 15
Rome 15
Santa Clara 15
Amsterdam 14
Orem 14
Manchester 13
Mexico City 13
Stockholm 13
Rio de Janeiro 12
St Petersburg 12
Atlanta 11
Poplar 11
Cesano Boscone 10
Frankfurt am Main 10
Houston 10
Pune 10
Rho 10
Phoenix 9
Querétaro 9
Ankara 8
Belo Horizonte 8
Gatchina 8
Toronto 8
Valencia 8
Haiphong 7
Mumbai 7
Tianjin 7
Vienna 7
Xi'an 7
Campinas 6
Charlotte 6
Council Bluffs 6
Doha 6
Falkenstein 6
Florence 6
Guangzhou 6
Lappeenranta 6
San Francisco 6
Biên Hòa 5
Brasília 5
Brussels 5
Curitiba 5
Dalmine 5
Fortaleza 5
Lima 5
Paris 5
Porto Alegre 5
Ribeirão Preto 5
Shenzhen 5
Turin 5
Yekaterinburg 5
Al Qatif 4
Amman 4
Assago 4
Bandung 4
Como 4
Da Nang 4
Montevideo 4
New Delhi 4
Pelotas 4
Pesaro 4
Philadelphia 4
Seriate 4
Shijiazhuang 4
Totale 3.026
Salva come PNG Salva come JPEG
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 349
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 326
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 319
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 318
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 314
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 305
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 202
Additional value of uterine artery Doppler pulsatility index for ultrasound diagnosis of placental site trophoblastic tumor: prospective cohort study 168
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 167
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 130
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 119
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 91
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 91
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 89
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 86
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 84
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 83
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 80
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 79
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 77
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 77
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 75
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group 74
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 74
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 74
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 74
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 70
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 69
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 69
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 68
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 63
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 61
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 61
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 60
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 60
Psychological aspects and fertility issues of GTD 60
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 59
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 58
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 58
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 57
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 57
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 56
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 56
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 55
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 54
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 54
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 53
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 52
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 52
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 52
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 51
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 51
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 51
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 50
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 49
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 49
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 49
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 47
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 47
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 45
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 45
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 45
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 43
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 43
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 43
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 42
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 42
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 41
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 40
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 40
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 40
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 40
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 39
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 39
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 39
Ovarian endometrioma: what the patient needs 38
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 38
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 37
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 36
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 36
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 36
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 36
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 35
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 35
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 35
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 34
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 33
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 33
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 32
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 31
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 31
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 31
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 31
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 30
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 30
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 29
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 29
Fertility preservation in women with cervical cancer 29
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 16
Totale 7.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.797
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 3 4 4 0 0 0 0
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20253.377 141 35 64 51 89 130 1.955 162 259 158 139 194
2025/20262.638 455 335 511 764 520 53 0 0 0 0 0 0
Totale 7.230